กรมการแพทย์ จับมือ สกสว. และ สไกน์เมด พัฒนา AI ผสานเซนเซอร์อัจฉริยะ – สำนักข่าวบางกอกทูเดย์

This collaboration focuses on combining sensor technology with AI algorithms to detect skin abnormalities and track the progression of dermatological conditions. The initiative aims to reduce the diagnostic burden on specialists and provide more accurate, real-time data for patient care.

The project integrates hardware sensors capable of capturing high-resolution skin data with software designed to analyze these patterns. According to Bangkok Today, the goal is to create a tool that assists healthcare providers in identifying skin pathologies more efficiently than traditional visual inspection alone.

Integration of AI and Smart Sensors in Dermatology

The technical framework of the partnership involves the use of smart sensors that can measure specific physiological markers of the skin. These sensors feed data into an AI system developed to recognize markers associated with various skin diseases, as reported by Bangkok Today.

By automating the initial screening process, the system is intended to flag high-risk cases for immediate physician review. This approach targets the gap in dermatological care where patient volume often exceeds the number of available specialists.

Public Health Impact and Clinical Application

The deployment of AI-driven sensors in clinical settings is expected to standardize the way skin lesions are recorded and monitored over time. According to the reporting from Bangkok Today, this technology allows for a more objective measurement of healing or disease progression compared to subjective visual assessments.

This system is particularly relevant for chronic skin conditions that require long-term monitoring. The ability to track changes in skin texture, moisture, or pigmentation via sensors provides a data-driven baseline for adjusting treatments.

Collaborative Framework and Development Goals

The project is structured as a tripartite agreement to ensure the technology moves from a research phase to actual clinical utility. TSRI provides the strategic research funding and coordination, while SkinMed handles the engineering of the smart sensors.

This ensures the AI is calibrated against verified clinical diagnoses rather than generic datasets.

Current development focuses on refining the sensitivity of the sensors to ensure they can detect subtle changes in the skin that are invisible to the human eye, according to the report by Bangkok Today.